In the Margins

Sanofi goes after Medivation board in takeover battle

May 25, 2016

By The New York Times

French pharmaceutical company Sanofi said it will seek to replace the board of Medivation after the American drug maker’s directors rejected a $9.3 billion takeover offer. Sanofi said in April that Medivation’s directors had failed to respond to its approach. Meanwhile, Medivation’s board called the offer “inadequate,” and founder and CEO David Hung has said the French company’s move was “opportunistically timed.” Read the original story from The New York Times.

 

 

Most Read

Top of the Agenda - Governance
Victory-USAA deal: New board leadership on deck

In an unusual move, the board overseeing USAA's mutual funds is planning to replace its long-serving independent chairman with an interested chair upon completion of Victory ...

Viewpoints
Government shutdown hits funds, fund boards

Many news reports have recounted how the partial government shutdown has affected government employees, shuttered national parks, and unsettled the stock market. But few, if any, ...